Bob More has departed Seattle-based growth equity and venture capital firm Frazier Healthcare to join the Bill and Melinda Gates Foundation.
More joined Frazier as a general partner in 2008. He was previously a partner at Domain Associates, a healthcare-focused venture firm he joined in 1996. From 1997 to 1998, More was the chief operating officer of Domain portfolio company Small Molecule Therapeutics.
At the Gates Foundation, More will focus on “developing and executing a venture capital initiative to support the goals of the foundation, focused primarily on diseases that affect the poorest people in the world”, he wrote in an email. “I'll also be looking at other strategic areas such as maternal and child health, nutrition and agriculture.”
During his time at Frazier, More led investments in businesses including cardiovascular therapeutics company NovaCardia, acquired by Merck for $350 million in 2007, and pharmaceutical company ESP Pharma, acquired by Protein Design Labs in 2005 for about $489 million.
Based in Seattle with offices in Washington DC, London, Delhi and Beijing, The Gates Foundation works with partner organisations to address global health issues. Led by Bill Gates, Melinda Gates and trustees including Warren Buffet, the foundation has an endowment of $36.4 billion and supports work in more than 100 countries.